Excluding Provisions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Excluding Provisions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Excluding Provisions Today - Breaking & Trending Today

Clarmin Explorations (CLXPF), COMP SERVICES (CMPS), FIELD TRIP HEALTH LTD by Field Trip Health Ltd. (FTRPF), JUSHI HLDGS INC CL B by Jushi Holdings Inc. (JUSHF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Published: February 15, 2021

RWB Received an $8 Million Warrant Exercise From an Institutional Investor and Signed an Irrevocable $7 Million Non-Convertible Debenture Unit Financing Commitment Red White & Bloom (OTCQX:RWBYF) announced that it has arranged the required cash for the closing of its previously announced acquisition of an Illinois Adult Use and Medical Cannabis Cultivation Center License and Associated Assets. Upon closing, and subject to regulatory approval, the Company intends to introduce both its Platinum Vape and High Times branded products into the Illinois market. “Surpassing USD $1 billion of...

Source: benzinga.com

Investorideas.com - Investor Ideas Potcasts #530, Cannabis News and Stocks on the Move; (TSX: TGOD) (OTC: TGODF) (NYSE: ACB) (TSX: ACB) (TSX: VLNS) (OTCQX: VLNCF)

Published: February 12, 2021

Investor Ideas Potcasts #530, Cannabis News and Stocks on the Move; (TSX: TGOD) (OTC: TGODF) (NYSE: ACB) (TSX: ACB) (TSX: VLNS) (OTCQX: VLNCF)

Source: investorideas.com

Aurora Cannabis Announces Fiscal 2021 Second Quarter Results

Published: February 11, 2021

Aurora Cannabis Announces Fiscal 2021 Second Quarter Results News provided by Share this article Share this article Total Cannabis Net Revenue of $70.3 Million, Excluding Provisions of $2.7 Million, Up 11% over Q2 2020 Medical Cannabis Net Revenue of $38.9 Million, Up 42% Versus Q2 2020, Driven by a 562% Increase in High Margin International Medical Sales Adjusted EBITDA Loss, excluding Provisions and Termination Costs, of $12.1 Million Represents an Improvement of $53.1 Million Over Q2 2020; Current Loss Triggered by Several Decisions Expected to Boost Long-Term Profitability Improved Cash U...

Source: prnewswire.com